ESMO – European Society for Medical Oncology shared on LinkedIn:
“ESMOImmuno25: From research to practice, together we advance cancer care.
Share your discoveries on a global stage and connect with leading researchers, clinicians and industry experts.
Abstract deadline: 30 September 2025
This congress is dedicated entirely to immuno-oncology across all tumour types – bringing together cutting-edge science, multidisciplinary expertise, and global perspectives.
New this year! Horizon sessions: These sessions connect current best practices with future breakthroughs, keeping you at the forefront of innovation.
From basic research and translational science to late-stage clinical development, our programme is designed to unite the scientific and medical communities. A dynamic environment where collaboration thrives and real-world impact is prioritised.”
More posts featuring ESMO.